Aldebaran Capital, LLC Pmv Pharmaceuticals, Inc. Transaction History
Aldebaran Capital, LLC
- $110 Billion
- Q3 2024
A detailed history of Aldebaran Capital, LLC transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Aldebaran Capital, LLC holds 438,252 shares of PMVP stock, worth $723,115. This represents 0.6% of its overall portfolio holdings.
Number of Shares
438,252
Previous 351,243
24.77%
Holding current value
$723,115
Previous $569 Million
14.76%
% of portfolio
0.6%
Previous 0.53%
Shares
2 transactions
Others Institutions Holding PMVP
# of Institutions
94Shares Held
43.4MCall Options Held
500Put Options Held
100-
Orbimed Advisors LLC San Diego, CA6.48MShares$10.7 Million0.25% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO2.8MShares$4.63 Million0.06% of portfolio
-
Sio Capital Management, LLC New York, NY2.71MShares$4.47 Million1.64% of portfolio
-
Euclidean Capital LLC New York, NY2.63MShares$4.34 Million0.54% of portfolio
-
Alkeon Capital Management LLC New York, NY2.34MShares$3.87 Million0.01% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $75.3M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...